Home › NDC Lookup › Ingredients › Aluminum Hydroxide And Magnesium Carbona... › 68016-0105-10
⚪image loading
(from DailyMed)

Premier Value Extra Strength Original Flavor aluminum hydroxide and magnesium carbonate 160 mg; 105 mg Tablet, Chewable, 100-count — NDC 68016-105-10 (Billing 68016-0105-10)

by PHARMACY VALUE ALLIANCE, LLC · 100 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC

This is a package of 100 tablets of Premier Value Extra Strength Original Flavor aluminum hydroxide and magnesium carbonate 160 mg; 105 mg Tablet, Chewable from PHARMACY VALUE ALLIANCE, LLC, marketed since Mar 2019 and currently FDA-listed. It is this product's only package size.

NDC 68016-0105-10
🏷️ FDA NDC (as labeled) 68016-105-10 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 68016-105-10
Product NDC 68016-105
11-digit billing NDC 68016010510
RxCUI 308072
UNII 5QB0T2IUN0, 0E53J927NA
UPC 0840986028656
Application # M001
SPL Set ID e33db45a-594e-4af8-ab16-10010fc8a388
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2019-03-20
Route ORAL
Dosage form TABLET, CHEWABLE
Substance ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE
Quick answers
  • RxCUI (RxNorm): 308072
Why two NDCs? The FDA registers this code as 68016-105-10 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 68016-0105-10. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Drugs for treatment of hyperkalemia and hyperphosphatemia class.

Drug family (ATC) Drugs for treatment of hyperkalemia and hyperphosphatemia, Magnesium compounds, Osmotically acting laxatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

🧪 What is this product?

Premier Value Extra Strength Original Flavor is a chewable tablet taken by mouth. It contains aluminum hydroxide and magnesium carbonate, two ingredients commonly used as antacids to help neutralize stomach acid and provide temporary relief from heartburn and indigestion. This product is an over-the-counter monograph drug, meaning it is sold under established FDA guidelines for antacid products rather than as an individually reviewed medication.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
68016-0105-10 You're viewing this Main listing 100 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC 2019-03-20 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Acid Gone Antacid Extra Strength 160 mg/1; 105 mg 00904-5365-60 Major 100 tablets $0.044 — Availability likely —
GOOD NEIGHBOR PHARMACY Antacid Extra Strength 160 mg/1; 105 mg 46122-0150-78 Amerisource 100 tablets $0.044 — Availability likely —
Extra Strength Antacid Original Flavor 160 mg/1; 105 mg 70000-0234-01 Cardinal 100 tablets $0.044 — Availability likely —
Gaviscon Extra Strength 160 mg/1; 105 mg 00135-0098-26 Haleon 100 tablets — — FDA listed —
Gaviscon Extra Strength 160 mg/1; 105 mg 00135-0430-03 Haleon 100 tablets — — FDA listed —
FAST ACTING Heartburn Relief 160 mg/1; 105 mg 00363-1155-10 WALGREEN 100 tablets — — FDA listed —
Extra Strength Antacid 160 mg/1; 105 mg 11673-0814-00 TARGET 100 tablets — — FDA listed —
Rite Aid Extra Strength 160 mg/1; 105 mg 11822-1050-00 RITE 100 tablets — — FDA listed —
Rite Aid Extra Strength 160 mg/1; 105 mg 11822-1051-00 RITE 100 tablets — — FDA listed —
HEB Extra Strength Original Flavor 160 mg/1; 105 mg 37808-0505-10 HEB 100 tablets — — FDA listed —
HEB Extra Strength Cherry Flavor 160 mg/1; 105 mg 37808-0510-10 HEB 100 tablets — — FDA listed —
Meijer Extra Strength Original Flavor 160 mg/1; 105 mg 41250-0675-10 MEIJER 100 tablets — — FDA listed —
equate Extra Strength Antacid 160 mg/1; 105 mg 49035-0105-10 Wal-Mart 100 tablets — — FDA listed —
CVS PHARMACY Extra Strength Cherry Flavor 160 mg/1; 105 mg 51316-0155-00 CVS 100 tablets — — FDA listed —
CVS Health Extra Strength Heartburn Relief Antacid Original Flavor 160 mg/1; 105 mg 59779-0880-78 CVS 100 tablets — — FDA listed —
Extra Strength Antacid Original Flavor 160 mg/1; 105 mg 63868-0996-01 CHAIN 100 tablets — — FDA listed —
Premier Value Extra Strength Original Flavor 160 mg/1; 105 mgthis 68016-0105-10 PHARMACY 100 tablets — — FDA listed —
Aluminum hydroxide and Magnesium carbonate 160 mg/1; 105 mg 76457-0001-00 Simpex 100 tablets — — FDA listed —
QUALITY CHOICE Original Flavor 160 mg/1; 105 mg 83324-0219-01 CHAIN 100 tablets — — FDA listed —
Kroger Extra Strength 160 mg/1; 105 mg 30142-0610-00 THE 100 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2019
On the market since
Mar 2019
📍
2026
Currently FDA-listed
7 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerPHARMACY VALUE ALLIANCE, LLC
FDA applicationM001 (OTC MONOGRAPH DRUG)
Labeler code68016
First marketedMar 2019
Product typeHuman Otc Drug
Portfolio26 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Ask a Doctor or Pharmacist Before Use If 📄 When Using This Product 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 17 words ▾

Uses relieves ▪ acid indigestion ▪ heartburn ▪ sour stomach ▪ upset stomach associated with these symptoms

⏱️ Dosage and Administration 48 words ▾

Directions ▪ chew 2 to 4 tablets completely four times a day or as directed by a doctor ▪ take after meals and at bedtime or as needed ▪ for best results follow by a half glass of water or other liquid ▪ DO NOT SWALLOW TABLETS WHOLE

⚠️ Warnings 80 words ▾

Warnings Ask a doctor or pharmacist before use if you are ▪ taking a prescription drug. Antacids may interact with certain prescription drugs ▪ If you are on a sodium-restricted diet When using this product ▪ do not take more than 16 tablets in 24 hours ▪ do not use the maximum dosage for more than 2 weeks Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center immediately at 1-800-222-1222.

🧪 Active Ingredient 13 words ▾

Active ingredients (in each tablet) Aluminum hydroxide 160 mg Magnesium carbonate 105 mg

🧪 Inactive Ingredients 18 words ▾

Inactive ingredients alginic acid, calcium stearate, compressible sugar, flavor, sodium bicarbonate, starch (corn), sucrose. Questions or comments? 1-866-467-2748

🎯 Purpose 3 words ▾

Purpose Antacid Antacid

📄 Ask a Doctor or Pharmacist Before Use If 30 words ▾

Ask a doctor or pharmacist before use if you are ▪ taking a prescription drug. Antacids may interact with certain prescription drugs ▪ If you are on a sodium-restricted diet

📄 When Using This Product 27 words ▾

When using this product ▪ do not take more than 16 tablets in 24 hours ▪ do not use the maximum dosage for more than 2 weeks

📄 Keep Out of Reach of Children 22 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center immediately at 1-800-222-1222.

📄 Questions or Comments 4 words ▾

Questions or comments? 1-866-467-2748

📄 Package Label / Principal Display Panel 115 words ▾

Principal Display Panel Premier Value ® NDC 68016-105-10 Heartburn Antacid COMPARE TO THE ACTIVE INGREDIENTS IN EXTRA STRENGTH GAVISCON ® EXTRA STRENGTH Aluminum Hydroxide, 160 mg Magnesium Carbonate, 105 mg Fast-Acting Heartburn Relief Helps Keep Acid Down for Hours 100 CHEWABLE TABLETS Distributed By: Pharmacy Value Alliance, LLC 407 East Lancaster Avenue, Wayne, PA 19087 DO NOT USE IF PRINTED INNER SEAL UNDER CAP IS BROKEN OR MISSING If for any reason you are not satisfied with this product, please return it to the store where purchased for a full refund. *This product is not manufactured or distributed by GlaxoSmithKline, the distributor of Gaviscon ® Extra Strength Antacid.

Heartburn Antacid Original Flavor 100 Chewable Tablets

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Premier Value Extra Strength Original Flavor (this brand).

Top reported reactions

Cerebral Haemorrhage2
Dizziness2
Headache2
Adverse Event1
Agitation1
Amnesia1
Balance Disorder1

Reporter sex

15 reports
Male · 29%
Female · 71%

Serious outcomes

Hospitalization7
Death2
Life-threatening1
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by PHARMACY VALUE ALLIANCE, LLC. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
PHARMACY VALUE ALLIANCE, LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 68016-0094-10 · Chain 68016-0106-08 · Pharmacy →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.